Department of Agriculture and published in the Journal of the American College of Nutrition found that chromium picolinate was better absorbed by the tissues (e.g., liver and muscle) than chromium nicotinate and chromium chloride. Additionally, an animal study conducted at the U.S. A human clinical study conducted by Ohio State University Department of Nutrition and presented at the 2005 Federation of American Societies for Experimental Biology (FASEB) annual meeting showed that chromium picolinate is better absorbed than other commercially available forms of chromium. Research indicates that chromium picolinate, the most studied form of chromium, has enhanced absorption and efficacy. Supplemental chromium is available in several forms, including chromium picolinate, chromium chloride, and chromium nicotinate. The authors concluded the greater bioavailability of chromium picolinate compared to other forms of chromium may explain its comparatively significant superior effects on glycemic and lipidemic control. Although glycemic control varied by trial, all 15 trials showed improvements in one or more measurements of glycemic control, including fasting glucose, postprandial glucose, fasting insulin, postprandial insulin, glycated hemoglobin, or insulin sensitivity. The studies examined people with type 2, type 1, gestational and corticosteroid-induced diabetes. All studies showed chromium picolinate produced benefits in one or more standard measures of diabetes management, with no adverse events reported. The review analyzed 15 clinical studies of people with diabetes. But separating out chromium picolinate, which yields highly consistent results in research studies, compared to other chromium supplements shows that at doses between 200-1000 mcg it is a superior nutritional adjunct to diabetes treatments." "Previous chromium reviews examined all types of chromium at widely varying doses. Leigh Broadhurst, PhD, Research Chemist, the lead author of the publication. "The main messages are that all forms of chromium are not equivalent, and that higher doses of chromium picolinate are required for people with type 2 diabetes," said C. The review, which analyzed research on chromium picolinate, supports the consistent beneficial effects of chromium picolinate and refutes a previous review that analyzed efficacy after combining results from all types of supplemental chromium. The analysis confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. has reported that a peer reviewed analysis on chromium picolinate was published in the current edition of Diabetes Technology & Therapeutics. Thus, do not take chromium and NSAIDs at the same time.- Supplemental chromium is available in several forms, including chromium picolinate, chromium chloride, and chromium nicotinate.ġ5/02/07 Nutrition 21, Inc. NSAIDs (Non-steroidal anti-inflammatory drugs) may increase chromium level in the blood, increasing the risk of hypoglycemia.Therefore, avoid taking chromium within 4 hours after taking levothyroxine. If you have hypothyroidism and are taking levothyroxine, chromium may decrease the absorption of the medication.When taking along with insulin or any other anti – diabetic medications, chromium might cause hypoglycemia.The following interactions should be kept in mind: To reduce craving for carbohydrates, a combination of chromium, glutamine, and 5 – HTP shows better results.Ĭhromium is taken orally 200 – 1000 mcg per day. Carving for carbohydrates during weight loss program.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |